Disclosures for "Regional Epidemiology of Status Epilepticus: Determinants for Healthcare Cost and Outcome in Central New York")
-
Dr. Gau has nothing to disclose.
-
Ms. Kleinhenz has nothing to disclose.
-
Dr. Cuello-Oderiz has nothing to disclose.
-
The institution of Dr. Izadyar has received research support from Xenon Pharmaceuticals. The institution of Dr. Izadyar has received research support from Ostuka Pharmaceuticals. An immediate family member of Dr. Izadyar has received publishing royalties from a publication relating to health care.